Category Archives: MS Treatment

Researchers at the University of Michigan developed an online tool to help people with multiple sclerosis (MS) manage some of the more life-affectingsymptomsof their disease. Continue reading →

WOBURN, Mass., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today announced the expansion of its executive team with the appointment of Jean M. Continue reading →

5. The Enforced Upgrade One Monday when Andrej was in pain and out of pills, the trauma doctor suggested we meet in the emergency room, because the trauma clinic was open only from 8 to 10:45 a.m. on Wednesdays and Thursdays Continue reading →

Neurological Research and Practice, the official journal of the German Neurological Society, launched its submission system about 1 year ago. Wed like to take this opportunity to talk about hot topics in neurology and the journals first year, with Professor Gereon Fink, Past President of the German Neurological Society Continue reading →

An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many investigators believe MS to be an autoimmune disease -- one in which the body, through its immune system, launches a defensive attack against its own tissues. In the case of MS, it is the nerve-insulating myelin that comes under assault. Such assaults may be linked to an unknown environmental trigger, perhaps a virus. Most people experience their first symptoms of MS between the ages of 20 and 40; the initial symptom of MS is often blurred or double vision, red-green color distortion, or even blindness in one eye. Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance. These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis. Most people with MS also exhibit paresthesias, transitory abnormal sensory feelings such as numbness, prickling, or "pins and needles" sensations. Some may also experience pain. Speech impediments, tremors, and dizziness are other frequent complaints. Occasionally, people with MS have … Continue reading →

Multiple sclerosis (MS) is difficult to diagnose, and, as yet, it has no cure. However, according to new research, it may be possible to slow its progression without some of the health risks associated with current treatments. MS is a chronic disease of the central nervous system (CNS) that disrupts nerve signals between the brain and the rest of the body Continue reading →

Steroids may be an effective treatment for multiple sclerosis relapses, but they have negative side effects. Continue reading →

November 27, 2019 09:00 ET | Source: Multiple Sclerosis Society of Canada multilang-release TORONTO, Nov. 27, 2019 (GLOBE NEWSWIRE) -- The Multiple Sclerosis (MS) Society of Canada announced today a $1 million donation from TD Bank Group to support research that uses artificial intelligence (AI) to develop clinical tools to enable more informed healthcare decisions in relation to disease-modifying therapies (DMTs) for people with MS. The funds will be directed towards the MS Societys Acts of Greatness campaign Continue reading →

GeNeuro is collaborating with clinical researchers at theKarolinska Institutet and the Academic Specialist Center (ASC) in Stockholm to open a new clinical trial of temelimab in people whosemultiple sclerosis (MS) is progressing in the absence of relapses. Fredrik Piehl, MD, PhD, a professor of neurology at Karolinska and head of research at the MS clinic at ASC, will lead this single-center trial at the ASCs Center for Neurology, the largest MS center in Sweden. Continue reading →

CBD (cannabidiol), which is one of the popular cannabinoids naturally occurring in the cannabis plant, has become a trendy topic in health and wellness forums. Continue reading →